1.Public and Private Hospitals in Kuala Lumpur and Selangor, Malaysia: How Do They Fare in Terms of Accessibility for the Physically Disabled?
Phua, K.L. ; Chong, J.C. ; Elangovan, R. ; Liew, Y.X. ; Ng, H.M. ; Seow, Y.W.
Malaysian Journal of Medicine and Health Sciences 2014;10(1):43-50
Public and private hospitals in Kuala Lumpur and Selangor were evaluated in terms of their accessibility
for the physically disabled. The research hypotheses for this study included the following: (1) Both
types of hospitals are accessible for the physically disabled as measured by specifi c criteria but (2)
the degree of accessibility is higher in the case of private hospitals as compared to public hospitals.
A total of 23 private hospitals and 11 public hospitals in Kuala Lumpur and Selangor were invited to
participate in the study. The 5 private hospitals and 5 public hospitals that agreed were evaluated for
adequacy of facilities for the physically-disabled. For this purpose, 13 specifi c criteria were assessed
and scored for each hospital. These criteria were also grouped into 5 categories, namely, parking, toilet,
door and lift, corridor and ramp. Scores were compared between each hospital and then aggregated
and compared for private hospitals versus public hospitals. It was found that none of the 5 private
hospitals and 5 public hospitals studied satisfi ed 100% of the criteria evaluated. Looking at each
hospital individually, the overall scores range from 32% to 92% for the criteria set. Only 4 of the 10
hospitals in our sample achieved overall scores of 80% or higher in terms of the evaluation criteria
we used. With the exception of availability of ramps where public hospitals scored slightly higher ,for
most of the individual criterion, private hospitals scored higher than public hospitals. Looking at each
criterion across all hospitals, the scores range from 59.2% (adequacy of parking) to 85% (adequacy of
corridors). The median score obtained by private hospitals and by public hospitals for all 13 criteria
were analysed for any difference. The difference between private hospitals and public hospitals is not
statistically signifi cant (Mann-Whitney U = 6.5, p-value = 0.099). There is no signifi cant difference
between Kuala Lumpur/Selangor private and public hospitals in terms of accessibility for physically
disabled people. However, some hospitals are more accessible for the physically disabled than other
hospitals. These fi ndings indicate that there is room for improvement.
Disabled Persons
;
Health Care Facilities, Manpower, and Services
2.Multimodal prerehabilitation for elderly patients with sarcopenia in colorectal surgery
Jingting WU ; Hannah CHI ; Shawn KOK ; Jason M.W. CHUA ; Xi-Xiao HUANG ; Shipin ZHANG ; Shimin MAH ; Li-Xin FOO ; Hui-Yee PEH ; Hui-Bing LEE ; Phoebe TAY ; Cherie TONG ; Jasmine LADLAD ; Cheryl H.M. TAN ; Nathanelle KHOO ; Darius AW ; Cheryl X.Z. CHONG ; Leonard M.L. HO ; Sharmini S. SIVARAJAH ; Jialin NG ; Winson J.H. TAN ; Fung-Joon FOO ; Bin-Tean TEH ; Frederick H. KOH
Annals of Coloproctology 2024;40(1):3-12
Sarcopenia, which is characterized by progressive and generalized loss of skeletal muscle mass and strength, has been well described to be associated with numerous poor postoperative outcomes, such as increased perioperative mortality, postoperative sepsis, prolonged length of stay, increased cost of care, decreased functional outcome, and poorer oncological outcomes in cancer surgery. Multimodal prehabilitation, as a concept that involves boosting and optimizing the preoperative condition of a patient prior to the upcoming stressors of a surgical procedure, has the purported benefits of reversing the effects of sarcopenia, shortening hospitalization, improving the rate of return to bowel activity, reducing the costs of hospitalization, and improving quality of life. This review aims to present the current literature surrounding the concept of sarcopenia, its implications pertaining to colorectal cancer and surgery, a summary of studied multimodal prehabilitation interventions, and potential future advances in the management of sarcopenia.